Microvascular Decompression (MVD) for Trigeminal Neuralgia: Benefits, Risks, and Questions Before Surgery

This article is educational and not medical advice. Decisions about surgery should always be made with a neurosurgeon and your wider care team.

Introduction: A Big Decision, Made Carefully

When a neurosurgeon first mentioned microvascular decompression to my mother, the room went very quiet. Brain surgery. For pain in her face. It sounded both terrifying and hopeful.

She did eventually have MVD, and we shared the full, honest story in My Mother's Experience With MVD Surgery: the immediate relief, the complications, and the pain returning months later. One experience cannot tell you what yours will be. But it taught us how important it is to understand the procedure properly before deciding.

This primer brings together what clinical guidance says about microvascular decompression for trigeminal neuralgia, so you can have a more informed conversation with your surgeon.

What Is Microvascular Decompression?

In many people with classic trigeminal neuralgia, a blood vessel, often an artery, presses against the trigeminal nerve where it leaves the brainstem. This contact is thought to contribute to the nerve misfiring.

MVD is an operation that aims to relieve this pressure. As Johns Hopkins Medicine and the NHS describe, it is performed under general anaesthetic. The surgeon makes an opening in the skull behind the ear, then moves the blood vessel away from the nerve and places a small cushion, often made of a soft material, between them.

Unlike some other procedures, MVD does not deliberately damage the nerve. That is one reason it is discussed differently from options like radiofrequency treatment, glycerol injection, balloon compression or stereotactic radiosurgery.

Why Imaging and Subtype Matter

Not everyone with trigeminal neuralgia is a candidate for MVD. The European Academy of Neurology guideline classifies TN into subtypes, and this classification influences surgical decisions.

• Classic TN is linked to a blood vessel compressing the nerve with structural changes. The guideline suggests MVD as a preferred surgical option for these patients when surgery is being considered.
• Idiopathic TN, where no clear compression is seen, has less certain evidence for MVD, and other options may be discussed.
• Secondary TN, caused by conditions such as multiple sclerosis or a tumour, is managed according to the underlying cause.

This is why a high-quality MRI, interpreted by an experienced team, is so important. Our article on how trigeminal neuralgia is diagnosed explains what MRI can and cannot show.

When MVD May Be Discussed

MVD is not an automatic next step. The EAN guideline and NHS suggest that surgery may be considered when medication does not control pain well enough, or when side effects are not tolerable. Carbamazepine or oxcarbazepine are first-line options, but every patient does not need to try both before a surgical discussion; our medications guide explains their role.

Other factors a team may consider include your general health, age, other conditions, how you feel about the risks of an operation, and your personal goals.

Potential Benefits

• Pain relief: Many people with classic TN experience significant pain relief after MVD, and for some this relief lasts for years.
• Reducing or stopping medication: Some people may be able to reduce medicines afterwards, under their clinician's supervision, which can mean fewer side effects.
• Nerve preservation: Because the nerve is not intentionally damaged, facial numbness is less common than with destructive procedures.

We are deliberately not quoting a single success rate. Reported outcomes vary between studies, surgical centres and patient groups, and depend heavily on TN subtype. Ask your surgeon what outcomes look like for patients like you at their centre.

Potential Risks

MVD is major surgery, and it carries risks. Sources such as the NHS and Johns Hopkins describe possibilities including:

• Hearing loss on the operated side
• Facial numbness or altered sensation
• Weakness of facial muscles
• Cerebrospinal fluid leak
• Infection, bleeding or wound problems
• Headaches, dizziness or balance problems during recovery
• Rare but serious complications such as stroke, and very rarely death

The likelihood of each depends on individual factors and the surgical team's experience. My mother experienced complications that we did not fully anticipate, which is exactly why we encourage open, detailed conversations before surgery.

Recovery Varies

Recovery is different for everyone. Typically, people stay in hospital for a few days and then need time at home to regain energy. Some feel well within weeks; others take longer, particularly if there are complications.

Practical preparation helped our family:

• Arranging help at home for the first weeks
• Preparing soft, easy meals in advance (see eating with trigeminal neuralgia)
• Planning time off work or responsibilities
• Writing down who to call with concerns after discharge

Caregivers may find our caregiver toolkit useful during recovery.

Pain Can Return

Even after a successful operation, pain can recur, sometimes months or years later. My mother's pain returned about four months after her surgery. This does not mean surgery was a mistake, and it does not mean nothing else can help. But it is an important possibility to understand before deciding.

Alternatives and Shared Decision-Making

Other procedures may be discussed, including stereotactic radiosurgery (such as Gamma Knife) and percutaneous procedures like radiofrequency thermocoagulation, glycerol injection and balloon compression. Each has a different balance of benefits, risks and recovery. Our surgery hub summarises these options.

Shared decision-making means you and your team weigh up the evidence together, alongside your values. There is rarely one "right" answer, and it is okay to take time, ask for a second opinion, and involve family.

Questions to Ask Your Neurosurgeon

• "What type of trigeminal neuralgia do you think I have, and what does my MRI show?"
• "Why do you think MVD could be right for me, or not?"
• "How many MVD operations do you and your team perform?"
• "What outcomes do patients like me typically have at this centre?"
• "What are the most common and most serious risks for me?"
• "What does recovery usually look like, and when can I return to normal activities?"
• "What happens if pain comes back?"
• "What are my alternatives, and what if I choose not to have surgery?"

Bring a support person to help remember answers. Our family support article explains why this matters so much.

Key Takeaways

• MVD aims to relieve blood vessel pressure on the trigeminal nerve.
• It is most often considered for classic TN when medication is not enough.
• Benefits can be significant, but risks are real and outcomes vary.
• Recovery differs between people, and pain can return.
• Decisions should be shared, unhurried and informed.

Frequently Asked Questions

What is microvascular decompression for trigeminal neuralgia?

It is an operation that moves a blood vessel away from the trigeminal nerve and places a small cushion between them to relieve pressure, without intentionally damaging the nerve.

Who is a candidate for MVD?

MVD is most often discussed for people with classic trigeminal neuralgia whose pain is not adequately controlled by medication or who cannot tolerate side effects. A neurosurgeon assesses each person individually.

What are the main risks of MVD?

Risks can include hearing loss, facial numbness or weakness, cerebrospinal fluid leak, infection, and rare serious complications such as stroke. Your surgeon can explain your individual risks.

Can trigeminal neuralgia come back after MVD?

Yes. Pain can return after MVD, sometimes months or years later. Outcomes vary from person to person.

Are there alternatives to MVD?

Yes. Alternatives include continued medication, stereotactic radiosurgery and percutaneous procedures such as radiofrequency treatment, glycerol injection and balloon compression.

Sources: European Academy of Neurology guideline (Bendtsen et al., 2019); NHS: Trigeminal neuralgia treatment; Johns Hopkins Medicine: Microvascular decompression surgery.